Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Mallinckrodt

This article was originally published in The Gray Sheet

Executive Summary

Mallinckrodt: Integration of the firm's Nellcor Puritan Bennett respiratory care acquisition, which closed in August, "is progressing well" and will largely be complete by the end of June, the firm reports Jan. 22. In preparing to take the next step to "strategically reposition the company with a single focus on its healthcare business," Mallinckrodt is "starting to explore" the divestiture of its $335 mil.-a-year industrial specialty chemicals business, and also is pursuing divestiture of an NPB aerospace equipment unit that makes oxygen equipment, passenger service units and video systems for the aerospace industry...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009474

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel